Immunohistochemistry revealed increased CD4+ and CD8+ T cells in AP-74 M-545-treated tumour tissues. AP-74 M-545 suppresses T cell apoptosis by blocking the binding of Galectin-1 to CD45, the main receptor and apoptosis mediator of galectin-1 on T cells. Here, PTPRC is linked to neoplasm.